Myriad Genetics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 200.4M | 209.8M | 205.7M | 213.1M | 195.9M | 210.6M | 213.3M | 211.5M |
| Cost of Goods Sold | 62.8M | 63.0M | 61.9M | 61.3M | 61.7M | 59.7M | 63.5M | 64.4M |
| Gross Profit | 137.6M | 146.8M | 143.8M | 151.8M | 134.2M | 150.9M | 149.8M | 147.1M |
| R&D Expenses | 27.1M | 25.5M | 28.2M | 25.6M | 27.5M | 32.2M | 28.5M | 27.1M |
| Operating Expenses | 162.9M | 152.5M | 167.1M | 481.0M | 163.2M | 189.9M | 169.8M | 183.6M |
| Operating Income | -25.3M | -5.7M | -23.3M | -329.2M | -29.0M | -39.0M | -20.0M | -36.5M |
| Other Income / Gains | -8.8M | -3.2M | -2.9M | -1.4M | -400K | -100K | -1.2M | -700K |
| Net Income | -34.1M | -7.9M | -27.4M | -330.5M | -100K | -42.5M | -22.1M | -36.7M |
| EPS (Diluted) | -0.36 | -0.085 | -0.29 | -3.57 | -0.001 | -0.47 | -0.24 | -0.41 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.687 | 0.70 | 0.699 | 0.712 | 0.685 | 0.717 | 0.702 | 0.696 |
| General And Administrative Expenses | 62.2M | 55.6M | 67.9M | 66.8M | 66.5M | -148.1M | 139.1M | 72.1M |
| Selling And Marketing Expenses | 73.6M | 68.7M | 71.0M | 71.9M | 69.2M | 284.1M | 0 | 72.8M |
| Selling General And Administrative Expenses | 135.8M | 124.3M | 138.9M | 138.7M | 135.7M | 136.0M | 139.1M | 144.9M |
| Other Expenses | 0 | 2.7M | 0 | 316.7M | 0 | 21.7M | 2.2M | 11.6M |
| Cost And Expenses | 225.7M | 215.5M | 229.0M | 542.3M | 224.9M | 249.6M | 233.3M | 248.0M |
| Interest Income | 700K | 800K | 500K | 200K | 300K | 300K | 400K | 400K |
| Interest Expense | 4.1M | 4.4M | 3.8M | 1.5M | 800K | 700K | 800K | 800K |
| Depreciation And Amortization | 12.5M | 12.6M | 12.6M | 14.1M | 14.4M | 14.8M | 15.6M | 15.1M |
| Ebitda | -17.5M | 8.1M | -9.8M | -315.0M | -14.2M | -23.6M | -4.8M | -21.3M |
| Ebitdaratio | -0.087 | 0.039 | -0.048 | -1.478 | -0.072 | -0.112 | -0.023 | -0.101 |
| Operating Income Ratio | -0.126 | -0.027 | -0.113 | -1.545 | -0.148 | -0.185 | -0.094 | -0.173 |
| Income Before Tax | -34.1M | -8.9M | -26.2M | -330.6M | -29.4M | -39.1M | -21.2M | -37.2M |
| Income Before Tax Ratio | -0.17 | -0.042 | -0.127 | -1.551 | -0.15 | -0.186 | -0.099 | -0.176 |
| Income Tax Expense | 0 | -1.0M | 1.2M | -100K | -29.3M | 3.4M | 900K | -500K |
| Net Income Ratio | -0.17 | -0.038 | -0.133 | -1.551 | -0.001 | -0.202 | -0.104 | -0.174 |
| Epsdiluted | -0.36 | -0.085 | -0.29 | -3.57 | -0.001 | -0.47 | -0.24 | -0.41 |
| Weighted Average Shs Out | 93.7M | 93.3M | 93.1M | 92.5M | 91.4M | 91.1M | 90.9M | 90.6M |
| Weighted Average Shs Out Dil | 93.7M | 93.3M | 93.1M | 92.5M | 91.4M | 91.1M | 90.9M | 90.6M |